The Government recently approved a policy for procuring medicines produced by Central PSUs, a move which aims at optimum utilisation of such units while ensuring availability of medicines at lower prices. The policy will be applicable to 103 medicines for five years and will be consumed by central government departments, Public Sector Undertakings and autonomous bodies.

The release mentioned that the renewal of the policy is aimed at ensuring optimum utilisation of the installed capacity of the pharma CPSEs. It would not only provide necessary fillip in reviving these CPSEs, which are ailing but also ensure availability of quality medicines at low prices to the masses. The policy will also be applicable to purchase of medicines by state governments under health programmes funded by the government such as the National Rural Health Mission.